60 Degrees Pharmaceuticals entered into inducement letter agreements with holders of existing warrants to exercise them at a reduced price of $0.90 per share, generating approximately $526,043 in gross proceeds. In exchange, the company issued new unregistered warrants for 1,168,984 shares, representing 200% of the exercised shares. The transaction is expected to close around November 9, 2026, subject to stockholder approval and customary conditions. Proceeds will support working capital and general corporate purposes. This biotechnology company focuses on developing pharmaceutical products.
